Cardiovascular Systems to Webcast Fiscal 2017 Second-Quarter Earnings Conference Call Wednesday, January 25
January 04 2017 - 4:05PM
Business Wire
Live Webcast at 3:45 p.m. CT (4:45 p.m.
ET)
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a
live webcast of its fiscal 2017 second-quarter conference call on
Wednesday, January 25, 2017, at 3:45 p.m. CT (4:45 p.m. ET). Scott
Ward, Chairman, President and Chief Executive Officer, and Larry
Betterley, Chief Financial Officer, will discuss the company’s
results for its fiscal second quarter ended December 31, 2016, and
its financial outlook. The company will issue a post-market
earnings release prior to the call on January 25.
To access the live webcast, go to the events section of the
company’s investor relations website,
http://investors.csi360.com/Investors/Events, on the day of the
conference call and click on the webcast link. A webcast replay
will be available beginning at 6:45 p.m. CT the same day.
To participate in the conference call, dial (877) 201-0168 and
enter 47648849. Please dial in at least 10 minutes prior to the
call.
If you do not have access to the Internet and want to listen to
an audio replay of the conference call, dial (855) 859-2056 and
enter 47648849. The audio replay will be available beginning at
6:45 p.m. CT on Wednesday, January 25, 2017, through 10:59 p.m. CT
on Wednesday, February 1, 2017.
About Cardiovascular Systems, Inc.Cardiovascular Systems,
Inc., based in St. Paul, Minn., is a medical device company focused
on developing and commercializing innovative solutions for treating
vascular and coronary disease. The company’s Orbital Atherectomy
Systems treat calcified and fibrotic plaque in arterial vessels
throughout the leg and heart in a few minutes of treatment time,
and address many of the limitations associated with existing
surgical, catheter and pharmacological treatment alternatives. The
U.S. FDA granted the first 510(k) clearance for the use of the
Orbital Atherectomy System in peripheral arteries in August 2007.
In October 2013, the company received FDA approval for the Coronary
Orbital Atherectomy System. To date, over 275,000 of CSI’s devices
have been sold to leading institutions across the United States.
For more information, visit the company’s website at
www.csi360.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170104005973/en/
Cardiovascular Systems, Inc.Jack Nielsen,
651-202-4919j.nielsen@csi360.comorPadillaCRTMatt Sullivan,
612-455-1709matt.sullivan@padillacrt.com
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Apr 2023 to Apr 2024